Literature DB >> 830169

Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein.

B Lahiri, A Bagdasarian, B Mitchell, R C Talamo, R W Colman.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 830169     DOI： 10.1016/0003-9861(76)90567-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  6 in total

1.  Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

Authors:  Yue Cao; Ake Lundwall; Virgil Gadaleanu; Hans Lilja; Anders Bjartell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor).

Authors:  K K Murthy; G Thibault; M Cantin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 3.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.

Authors:  M Schapira; C F Scott; R W Colman
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

5.  Inactivation of kallikrein in human plasma.

Authors:  F van der Graaf; J A Koedam; B N Bouma
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

6.  Plasma kallikrein activation and inhibition during typhoid fever.

Authors:  R W Colman; R Edelman; C F Scott; R H Gilman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.